Pharma & Biotech

Biotech firm Replimune confronts a pivotal moment for its future as it engages in a decisive Type-A meeting with U.S....

Axsome Therapeutics finds itself navigating a complex landscape as generic manufacturer Apotex Inc. launches a legal challenge against the market...

A significant regulatory milestone in Europe has positioned Abbott Laboratories for accelerated growth within its structural heart business. The medical...

Johnson & Johnson is demonstrating robust performance across its two primary business segments. The company's oncology franchise is being powered...

Gilead Sciences appears to be on the cusp of a significant transformation. The biotechnology firm's stock is exhibiting robust technical...

The biotechnology giant Amgen finds itself navigating a complex landscape where groundbreaking innovation collides with mounting competitive pressures. While the...

Viracta Therapeutics has officially terminated all business activities, marking a complete wind-down of the company. The firm's website now confirms...

Alzamend Neuro's stock experienced a slight uptick in today's trading session, advancing $0.01 or 0.41% to close at $2.44. The...

Institutional confidence in Puma Biotechnology appears to be mounting, as evidenced by substantial position increases from several major investment houses....

Pfizer has secured a critical regulatory milestone, receiving FDA approval for its updated COVID-19 vaccine, COMIRNATY LP.8.1. However, the triumph...